Streetbeat News

Regulatory

MYNZ

Mainz Biomed N.V. (NASDAQ:MYNZ) is collaborating with TestDNA to present at the 10th Gdańsk Gastroenterology Symposium, focusing on the need for earlier detection of colorectal cancer (CRC). They will discuss non-invasive screening methods like ColoAlert, Mainz Biomed's at-home CRC screening kit. ColoAlert offers higher sensitivity and specificity than traditional fecal occult blood tests and is available in select EU countries. The US market represents a significant opportunity for ColoAlert, pending FDA approval from the ReconAAsense trial.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 1:05 pm

LNTH

Lantheus Holdings, Inc. has announced that the FDA has accepted its first-to-file Abbreviated New Drug Application (ANDA) for a generic version of Lutathera, which is used to treat somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors. This acceptance could potentially allow Lantheus to enter the market with its generic product upon patent expiration, subject to FDA approval.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 1:02 pm

ALK

BA

RYAAY

SPR

Ryanair CEO Michael O'Leary stated that passengers are not concerned about flying on Boeing 737 aircraft despite recent safety issues. The FAA grounded 171 MAX 9 jets after a cabin panel incident on an Alaska Airlines flight. O'Leary confirmed that the issue does not affect Ryanair's MAX 8 or the MAX 10 models on order. He expressed confidence in Boeing's leadership but noted quality control issues at Boeing and supplier Spirit Aerosystems. Ryanair's stock (RYAAY) is trading higher by 0.89% premarket.

Portfolio Pulse from Nabaparna Bhattacharya

January 11, 2024 | 12:55 pm

SOBR

Sobr Safe, Inc. has filed a U.S. patent application for a wearable data collection device with non-invasive sensing. The patent application number is 20240008812. This development could potentially enhance the company's product offerings in the field of personal safety and sobriety monitoring.

Portfolio Pulse from Charles Gross

January 11, 2024 | 12:55 pm

SNGX

Soligenix and the University of Hawaii have filed a U.S. patent application (#20240009297) for antibody/adjuvant compositions aimed at generating an immune response against coronaviruses. The patent application could potentially cover new technologies or methods that may enhance the effectiveness of coronavirus treatments or vaccines.

Portfolio Pulse from Charles Gross

January 11, 2024 | 12:48 pm

SEEL

Seelos Therapeutics has filed a U.S. patent application (#20240009113) for the treatment of protein aggregation myopathic and neurodegenerative diseases through the parenteral administration of Trehalose. The patent filing could potentially strengthen Seelos' intellectual property portfolio and support the development of its therapeutic pipeline.

Portfolio Pulse from Charles Gross

January 11, 2024 | 12:37 pm

SHFS

SHF Holdings (SHFS) has regained compliance with Nasdaq's Listing Rule 5550(a)(2) according to a statement on January 5, 2024. The company had previously been out of compliance with the rule, which could have led to delisting from the Nasdaq exchange if not addressed.

Portfolio Pulse from Charles Gross

January 11, 2024 | 12:35 pm

LIDR

AEye, Inc. has filed a U.S. patent application (#20240012118) for a method and system for optical data communication via LADAR (Laser Detection and Ranging). The patent application suggests AEye's focus on innovation in LADAR technology, which is critical for applications such as autonomous driving. The company's public float is 5,557,018 shares.

Portfolio Pulse from Charles Gross

January 11, 2024 | 12:21 pm

SVFD

Save Foods, through its majority-owned subsidiary Nitrousink, has filed a patent application with the USPTO for a solution aimed at reducing greenhouse gas emissions in wheat production.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 12:18 pm

MSFT

QQQ

Microsoft Corp is considering the future of its AI lab in Beijing due to security concerns and potential national security risks. U.S. lawmakers have warned about the dangers of tech collaboration with China. Debates have included options like relocating or shutting down the lab. Microsoft has taken measures to protect its technology and restrict sensitive research. Despite concerns, Microsoft remains committed to China's digital transformation, with a significant presence in the country. Microsoft stock outperformed Invesco QQQ Trust last year.

Portfolio Pulse from Anusuya Lahiri

January 11, 2024 | 12:17 pm